Colorado Therapeutics
Focus: Colorado Therapeutics is a private-stage biotechnology company focused on crosslinked soft tissue repair materials with oncology applications. The company operates at pre-commercial scale with a highly experimental pipeline.
Profile data last refreshed 22h ago · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Open Jobs
0
About Colorado Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Colorado Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Griseofulvin Ultramicrosize
Declining
Post-LOE
Generic antifungal post-exclusivity; likely acquired asset with minimal strategic value.
Cyproheptadine HCl
Help build intelligence for Colorado Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.